Implementation of accelerated research: strategies for implementation as applied in a phase 1 Ad26.ZEBOV, MVA-BN-Filo two-dose Ebola vaccine clinical trial in Uganda

BACKGROUND: The 2013–2016 Ebola epidemic in West Africa is the worst ever caused by Ebolaviruses with over 28,000 human cases and 11,325 deaths. The World Health Organisation (WHO) declared the epidemic a public health crisis that required accelerated development of novel interventions including vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitonsa, Jonathan, Ggayi, Abu-Baker, Anywaine, Zacchaeus, Kisaakye, Eva, Nsangi, Laura, Basajja, Vincent, Nyantaro, Mary, Watson-Jones, Deborah, Shukarev, Georgi, Ilsbroux, Ine, Robinson, Cynthia, Kaleebu, Pontiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594841/
https://www.ncbi.nlm.nih.gov/pubmed/33073737
http://dx.doi.org/10.1080/16549716.2020.1829829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594841/
https://www.ncbi.nlm.nih.gov/pubmed/33073737
http://dx.doi.org/10.1080/16549716.2020.1829829

Ejemplares similares